426
P. Radha Krishna et al. / Tetrahedron: Asymmetry 14 (2003) 419–427
4.2.7. Cyclisation of the mixture 19 and 4b. A solution
of the mixture of 19+4b (0.5 g, 1.2 mmol) in methanol
(10 mL) was treated with K2CO3 (0.16 g, 1.2 mmol) and
heated under reflux for 4 h. Work up of the reaction as
reported for 10 gave the residue, which was purified by
column chromatography (silica gel, 100–200 mesh,
EtOAc:hexane, 3:20). First eluted was 2-[2%,2%-dimethyl-
(4%S)-1%,3%-dioxolan-4%-yl]-6-phenyl-(2R,6S)-3,6-dihydro-
2H-pyran 22 as a syrup (0.033 g, 22%). [h]2D5 −17.8 (c
4.2.9.
6-[2%,2%-Dimethyl-(4%S)-1%,3%-dioxolan-4%-yl]-4-
methoxy - 2 - phenyl - (2S,3R,4S,6R) - tetrahydro - 2H - 3-
pyranyl acetate, 3. A solution of 22 (0.10 g, 0.32 mmol)
in pyridine (0.5 mL) containing DMAP (catalytic) was
treated with Ac2O (0.03 mL, 0.32 mmol) at 0°C and
stirred for 1 h at room temperature. Work up of the
reaction as described for 1 and purification by column
chromatography (silica gel, 100–200 mesh, EtOAc:
hexane, 1:4) gave 6-[2%,2%-dimethyl-(4%S)-1%,3%-dioxolan-
4%-yl]-4-methoxy-2-phenyl-(2S,3R,4S,6R)-tetrahydro-
2H-3-pyranyl acetate, 3 as a syrup (0.10 g, 92%). [h]D25
1
0.8, CHCl3); H NMR (200 MHz, CDCl3): l 7.4–7.2
(m, 5H, Ar-H), 5.8–5.9 (dt, 1H, J=2.6 Hz, H-4),
5.7–5.6 (dd, 1H, J=5.2, 2.6 Hz, H-5), 5.2 (m, 1H, H-6),
4.5 (m, 1H, H-2), 4.1 (m, 2H, H-5%), 3.59 (dt, 1H,
J=5.2 Hz, H-4%), 1.9 (m, 2H, H-3), 1.4–1.35 (br.s, 6H,
CH3). EIMS (m/z): 260 (M+). Anal. calcd for C16H20O3:
C, 73.8; H, 7.7; found: C, 73.6; H, 7.8%.
1
−6.4 (c 0.5, CHCl3); H NMR (400 MHz, CDCl3): l
7.4–7.2 (m, 5H, Ar-H), 5.25 (dd, 1H, J3,2=4.6, J3,4=6.8
Hz, H-3), 4.2 (d, 1H, J2,3=4.6 Hz, H-2), 4.05 (m, 2H,
H-4,5%a), 3.99 (ddd, 1H, J6,4%=6.0, J6,5a=2.6, J6,5b=9.7
Hz, H-6), 3.87 (m, 2H, H-4%,5%b), 3.25 (s, 3H, OCH3),
2.01 (m, 1H, H-5a), 1.98 (s, 3H, OAc), 1.78 (ddd, 1H,
Second eluted was 6-[2%,2%-dimethyl-(4%S)-1%,3%-dioxolan-
4%-yl]-3-methoxy-2-phenyl-(2S,3S,4R,6R)-tetrahydro-
2H-4-pyranol, 20 as a syrup (0.06 g, 34%). [h]2D5 −18.7
J5b,6=9.7, J5a,5b=13.7, J5b,4=5.6 Hz, H-5b), 1.4, 1.38
(2s, 6H, CH3). FABMS (m/z): 350 (M+).
1
(c 1.2, CHCl3); H NMR (200 MHz, CDCl3): l 7.4–7.2
(m, 5H, Ar-H), 4.3 (m, 1H, H-4), 4.1 (d, 1H, J=3.1 Hz,
H-2), 3.95 (m, 2H, H-3,5%a), 3.85 (dt, 1H, J=4.7 Hz,
H-6), 3.75 (m, 2H, H-4%,5%b), 3.25 (s, 3H, OCH3), 2.1
(m, 2H, H-5), 1.38, 1.36 (2s, 6H, CH3). Anal. calcd for
C17H25O5: C, 66.0; H, 8.1; found: C, 66.1; H, 8.0%.
Acknowledgements
B. Lavanya acknowledges the financial support in the
form of a fellowship from the CSIR, New Delhi, India.
Thirdelutedwas6-[2%,2%-dimethyl-(4%S)-1%,3%-dioxolan-4%-
yl] - 4 - methoxy - 2 - phenyl - (2S,3R,4S,6R) - tetrahydro-
2H-3-pyranol 21 as a syrup (0.021 g, 12%). [h]2D5 +2.66
References
1
(c 1.2, CHCl3); H NMR (200 MHz, CDCl3): l 7.4–7.2
1. (a) Anthracycline Antibiotics; E. I. Khadem, H. S., Ed.;
Academic Press: New York, 1992; (b) Lee, M. D.;
Dunne, T. S.; Chang, C. C.; Ellestad, G. A.; Siegel, M.
M.; Morton, G. O.; McGahren, W. J.; Borders, D. B. J.
Am. Chem. Soc. 1987, 109, 3466–3468; (c) Roush, W. R.;
Lin, X.-F. J. Org. Chem. 1991, 56, 5740–5742.
(m, 5H, Ar-H), 4.3 (m, 1H, H-4), 4.2 (dd, 1H, J=4.4,
6.6 Hz, H-3), 4.1 (d, 1H, J=4.4 Hz, H-2), 4.0 (m, 1H,
H-6), 3.9 (m, 2H, H-4%, 5%a), 3.6 (dd, 1H, J=4.4, 2.2
Hz, H-5%b), 3.25 (s, 3H, OCH3), 2.2 (ddd, 1H, J=6.7,
4.4, 2.2 Hz, H-5a), 1.8 (m, 1H, H-5b), 1.3, 1.2 (2s, 6H,
CH3).
2. Du, Y.; Linhardt, R. J.; Vlahov, I. R. Tetrahedron 1998,
54, 9913–9959.
4.2.8.
6-[2%,2%-Dimethyl-(4%S)-1%,3%-dioxolan-4%-yl]-3-
3. (a) Hadfield, A. F.; Sartoslli, A. F. Carbohydr. Res. 1982,
701, 197–208; (b) Ciment, D. M.; Ferrier, R. J. J. Chem.
Soc. 1980, 441–445; (c) Grynkiewicz, G.; Priebe, W.;
Zamojski, A. Carbohydr. Res. 1979, 68, 33–41.
4. (a) Hocksell, A.; Daves, G. D. J. Prog. Med. Chem. 1985,
22, 1–65; (b) Franz, G.; Gruen, M. Plasta 1983, 47,
131–140.
5. (a) Toshima, K.; Matsuo, G.; Nakata, M. J. Chem. Soc.,
Chem. Commun. 1994, 199–200; (b) Allev, P.; Anastasia,
M.; Ciuffreda, P.; Fiecchi, A.; Scala, A.; Bingham, S.;
Muir, M.; Tyman, J. J. Chem. Soc., Chem. Commun.
1991, 1319–1320; (c) Parker, K. A.; Coburn, C. A. J. Am.
Chem. Soc. 1991, 113, 8516–8518; (d) Daves, G. D. J.
Acc. Chem. Res. 1990, 23, 201–206; (e) Bellosta, V.;
Czernecki, S. J. Chem. Soc., Chem. Commun. 1989, 199–
200; (f) Czeonecki, S.; Vilee, G. J. Org. Chem. 1989, 54,
610–612; (g) Casiraghi, G.; Cornia, M.; Colombo, L.;
Rassu, G.; Favo, G. G.; Bericch, M. F.; Zetta, L. Tetra-
hedron Lett. 1988, 29, 5549–5552; (h) Schmidt, R. R.;
Frick, W.; Haag-Zieno, B.; Apaarao, S. Tetrahedron Lett.
1987, 28, 4045–4048; (i) Bellosta, V.; Czernecki, S. Carbo-
hydr. Res. 1987, 171, 279–288.
methoxy - 2 - phenyl - (2S,3S,4R,6R) - tetrahydro - 2H - 4-
pyranyl acetate, 2. A solution of 20 (0.1 g, 0.32 mmol)
in pyridine (0.5 mL) containing DMAP (catalytic) was
treated with Ac2O (0.03 mL, 0.32 mmol) at 0°C and
stirred for 1 h at room temperature. The reaction
mixture was worked up as described for 1 and purified
by column chromatography (silica gel, 100–200 mesh,
EtOAc:hexane, 1:4) to afford 6-[2%,2%-dimethyl-(4%S)-
1%,3%-dioxolan-4%-yl]-3-methoxy-2-phenyl-(2S,3S,4R,6R)-
tetrahydro-2H-4-pyranyl acetate, 2 as a thick syrup
1
(0.10 g, 92%). [h]2D5 −20.5 (c 1.0, CHCl3); H NMR (400
MHz, CDCl3): l 7.4–7.2 (m, 5H, Ar-H), 5.3 (dt, 1H,
J4,3=4.6, J4,5=6.0 Hz, H-4), 4.22 (d, 1H, J2,3=2.2 Hz,
H-2), 4.11 (dd, 1H, J3,2=2.2, J3,4=4.6 Hz, H-3), 4.06
(m, 1H, H-5%a), 3.99 (ddd, 1H, J6,4%=6.0, J6,5a=2.6,
J
6,5b=9.7 Hz, H-6), 3.87 (m, 2H, H-4%,5%b), 3.25 (s, 3H,
OCH3), 2.01 (ddd, 1H, J5a,6=2.2, J5a,5b=13.7, J5a,4
5.6 Hz, H-5a), 1.98 (s, 3H, OAc), 1.79 (ddd, 1H,
=
J
5b,6=9.7, J5a,5b=13.7, J5b,4=5.6 Hz, H-5b), 1.38, 1.34
(2s, 6H, CH3). 13C NMR (50 Hz, CDCl3): l 21.26,
25.46, 28.68, 29.77, 35.86, 57.34, 67.59, 75.51, 76.83,
79.87, 84.01, 87.54, 127.71, 128.32. FABMS (m/z): 350
(M+). Anal. calcd for C19H26O6: C, 65.13; H, 7.48;
found: C, 65.11; H, 7.44%.
6. (a) Kometani, T.; Konda, H.; Fujimori, Y. Synthesis
1988, 1005–1007; (b) Matsumoto, T.; Katsuki, M.;
Suzuki, K. Tetrahedron Lett. 1988, 29, 6935–6938; (c)